The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes
- PMID: 16930770
- DOI: 10.1016/j.jhin.2006.06.025
The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes
Abstract
Risk factors and outcomes for patients with nosocomial Acinetobacter baumannii bacteraemia were compared with those for patients with nosocomial Klebsiella pneumoniae bacteraemia in a single centre in Israel between 2000 and 2003. Data were collected retrospectively through patient chart review. In total, 112 patients with A. baumannii bacteraemia and 90 patients with K. pneumoniae bacteraemia were identified. A. baumannii was significantly associated with poorer performance status, mechanical ventilation, presence of devices, prior treatment with carbapenems, pneumonia as the source of infection and inappropriate empirical antibiotic treatment. All-cause 30-day mortality was higher for A. baumannii bacteraemia compared with K. pneumoniae bacteraemia (61.6% vs 38.9%, P=0.001). Variables significantly associated with mortality at the univariate level (P<0.1) were entered into a multi-variable logistic regression model for mortality. A. baumannii remained significantly associated with mortality when adjusted for all other risk factors (odds ratio 3.61, 95% confidence interval 1.55-8.39). This result did not change when the analysis was repeated for subgroups of less severely ill patients, i.e. those who were not ventilated and those who did not present with septic shock. These results support the view that nosocomial bacteraemia due to A. baumannii is associated with increased mortality.
Similar articles
-
Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.Int J Antimicrob Agents. 2007 Nov;30(5):409-14. doi: 10.1016/j.ijantimicag.2007.06.026. Epub 2007 Sep 11. Int J Antimicrob Agents. 2007. PMID: 17851052
-
Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.Eur J Intern Med. 2009 Sep;20(5):540-4. doi: 10.1016/j.ejim.2009.05.005. Epub 2009 May 29. Eur J Intern Med. 2009. PMID: 19712862
-
Mortality risk factors of Acinetobacter baumannii bacteraemia.Intern Med J. 2005 Oct;35(10):599-603. doi: 10.1111/j.1445-5994.2005.00925.x. Intern Med J. 2005. PMID: 16207259
-
Therapeutic options for Acinetobacter baumannii infections.Expert Opin Pharmacother. 2008 Mar;9(4):587-99. doi: 10.1517/14656566.9.4.587. Expert Opin Pharmacother. 2008. PMID: 18312160 Review.
-
Acinetobacter baumannii skin and soft-tissue infection associated with war trauma.Clin Infect Dis. 2008 Aug 15;47(4):444-9. doi: 10.1086/590568. Clin Infect Dis. 2008. PMID: 18611157 Review.
Cited by
-
Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections.Infect Dis Ther. 2017 Jun;6(2):149-172. doi: 10.1007/s40121-017-0149-y. Epub 2017 Mar 4. Infect Dis Ther. 2017. PMID: 28260148 Free PMC article. Review.
-
Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.Public Health Rep. 2009 Nov-Dec;124(6):868-74. doi: 10.1177/003335490912400615. Public Health Rep. 2009. PMID: 19894430 Free PMC article.
-
The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.Infect Immun. 2010 Sep;78(9):3993-4000. doi: 10.1128/IAI.00366-10. Epub 2010 Jul 19. Infect Immun. 2010. PMID: 20643860 Free PMC article.
-
Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.J Bacteriol. 2008 Dec;190(24):8053-64. doi: 10.1128/JB.00834-08. Epub 2008 Oct 17. J Bacteriol. 2008. PMID: 18931120 Free PMC article.
-
Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1073-1081. doi: 10.1007/s10096-016-2895-2. Epub 2017 Jan 18. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28101785
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources